Galapagos NV
GLPG
#4561
Rank
โ‚น199.59 B
Marketcap
โ‚น3,029
Share price
-1.50%
Change (1 day)
47.26%
Change (1 year)

Earnings for Galapagos NV (GLPG)

Earnings in 2025 (TTM): -โ‚น46.41 Billion

According to Galapagos NV's latest financial reports the company's current earnings are โ‚น0.32 Billion. In 2024 the company made an earning of -โ‚น0.53 Billion, an increase over its 2023 earnings that were of -โ‚น3.04 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Galapagos NV from 2015 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น46.41 Billion8786.77%
2024 -โ‚น0.53 Billion-82.77%
2023 -โ‚น3.04 Billion-85.59%
2022 -โ‚น21.04 Billion60.71%
2021 -โ‚น13.1 Billion-60.08%
2020 -โ‚น32.8 Billion-331.44%
2019 โ‚น14.16 B-523.76%
2018 -โ‚น3.35 Billion-72.34%
2017 -โ‚น12.09 Billion-329.59%
2016 โ‚น5.26 B-144.3%
2015 -โ‚น11.89 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
AstraZeneca
AZN
โ‚น1.182 T-2,558.70%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
โ‚น2.927 T-6,184.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น822.31 B-1,809.31%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
โ‚น150.00 B-411.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
-โ‚น4.84 Billion-89.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น735.36 B-1,628.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น160.12 B-432.84%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
โ‚น842.43 B-1,851.12%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
โ‚น2.086 T-4,437.01%๐Ÿ‡บ๐Ÿ‡ธ USA